Benzinga··Vandana SinghBoston Scientific Bets $1.5B on Heart Valve Innovation to Capture Aortic Stenosis Market
Boston Scientific invests $1.5B for 34% stake in MiRus, securing exclusive TAVR device rights. Stock surges 5.56% on strategic structural heart market bet.
BSXacquisitionclinical trial